The RASopathies: from pathogenetics to therapeutics

KE Hebron, ER Hernandez… - Disease models & …, 2022 - journals.biologists.com
The RASopathies are a group of disorders caused by a germline mutation in one of the
genes encoding a component of the RAS/MAPK pathway. These disorders, including …

The RASopathy family: consequences of germline activation of the RAS/MAPK pathway

M Tajan, R Paccoud, S Branka, T Edouard… - Endocrine …, 2018 - academic.oup.com
Abstract Noonan syndrome [NS; Mendelian Inheritance in Men (MIM)# 163950] and related
syndromes [Noonan syndrome with multiple lentigines (formerly called LEOPARD …

Costello syndrome: Clinical phenotype, genotype, and management guidelines

KW Gripp, LA Morse, M Axelrad… - American Journal of …, 2019 - Wiley Online Library
Costello syndrome (CS) is a RASopathy caused by activating germline mutations in HRAS.
Due to ubiquitous HRAS gene expression, CS affects multiple organ systems and …

The ras superfamily of small gtpases in non-neoplastic cerebral diseases

L Qu, C Pan, SM He, B Lang, GD Gao… - Frontiers in molecular …, 2019 - frontiersin.org
The small GTPases from the Ras superfamily play crucial roles in basic cellular processes
during practically the entire process of neurodevelopment, including neurogenesis …

Mitochondrial functions and rare diseases

L Dard, W Blanchard, C Hubert, D Lacombe… - Molecular Aspects of …, 2020 - Elsevier
Mitochondria are dynamic cellular organelles responsible for a large variety of biochemical
processes as energy transduction, REDOX signaling, the biosynthesis of hormones and …

Genotype‐cardiac phenotype correlations in a large single‐center cohort of patients affected by RASopathies: Clinical implications and literature review

C Leoni, R Blandino, AB Delogu… - American Journal of …, 2022 - Wiley Online Library
Congenital heart disease (CHD) and hypertrophic cardiomyopathy (HCM) are common
features in patients affected by RASopathies. The aim of this study was to assess genotype …

Noonan syndrome: an update on growth and development

A Yart, T Edouard - Current Opinion in Endocrinology, Diabetes …, 2018 - journals.lww.com
Noonan syndrome: an update on growth and development : Current Opinion in
Endocrinology, Diabetes and Obesity Noonan syndrome: an update on growth and …

[HTML][HTML] RAS signalling in energy metabolism and rare human diseases

L Dard, N Bellance, D Lacombe, R Rossignol - Biochimica Et Biophysica …, 2018 - Elsevier
The RAS pathway is a highly conserved cascade of protein-protein interactions and
phosphorylation that is at the heart of signalling networks that govern proliferation …

Inside the Noonan “universe”: Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns

S Stagi, V Ferrari, M Ferrari, M Priolo… - Frontiers in …, 2022 - frontiersin.org
Noonan syndrome (NS) is a disorder characterized by a typical facial gestalt, congenital
heart defects, variable cognitive deficits, skeletal defects, and short stature. NS is caused by …

Management of nutritional and gastrointestinal issues in RASopathies: A narrative review

R Onesimo, V Giorgio, G Viscogliosi… - American Journal of …, 2022 - Wiley Online Library
Noonan, Costello, and cardio‐facio‐cutaneous syndrome are neurodevelopmental
disorders belonging to the RASopathies, a group of syndromes caused by alterations in the …